Patents Assigned to Tularix Inc.
  • Arylsulfonanilide derivates
    Patent number: 6630513
    Abstract: The invention provides compounds, compositions and methods relating to novel arylsulfonanilide derivatives and their use as pharmacologically active agents. The compositions find particular use as pharmacological agents in the treatment of disease states, particularly cancer, psoriasis, vascular restenosis, infections, atherosclerosis and hypercholesterolemia, or as lead compounds for the development of such agents.
    Type: Grant
    Filed: September 27, 2000
    Date of Patent: October 7, 2003
    Assignee: Tularix Inc.
    Inventors: Steven M. Rubenstein, Juan C. Jaen